首页> 美国卫生研究院文献>Springer Open Choice >SVHC in imported articles: REACH authorisation requirement justified under WTO rules
【2h】

SVHC in imported articles: REACH authorisation requirement justified under WTO rules

机译:进口物品中的SVHC:REACH授权要求符合WTO规则

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The purpose of the REACH Regulation is to ensure a high level of protection of human health and the environment as well as the free circulation of substances on the internal market while enhancing competitiveness and innovation. To this end, REACH introduces, among other instruments, the authorisation regime for substances of very high concern (SVHC) that are listed on Annex XIV of the regulation. After expiration of the transitional period for each Annex XIV-SVHC, articles, such as most products of daily use, produced in the European Economic Area (EEA) may not contain such substances unless an authorisation was granted for the specific use or this use falls within the scope of an exemption from the authorisation requirement. The authorisation scheme does, however, only apply to SVHC used in the EEA. As a consequence, REACH does not regulate SVHC entering the European market as part of imported articles which burden human health and the environment. Moreover, from an economic perspective, domestic articles are subject to stricter requirements than those which are produced abroad, putting actors from within the EEA at competitive disadvantage and thus impeding the intention of REACH to enhance competitiveness and innovation. One option to close this regulatory gap could be to extend the authorisation requirement to SVHC present in imported articles. A legal appraisal on behalf of the German Environment Agency (UBA) assesses whether such option would be in accordance with the specifications of WTO world trade law. It concludes that, measured by the standards of the WTO dispute settlement practice, such an extended authorisation scheme would neither violate the principles of national treatment and most-favoured nation treatment. Also, such regulation would not constitute an unnecessary obstacle to trade, since the extended authorisation requirement would pursue a legitimate objective covered by the regulatory autonomy of the EU and, furthermore, the regulation would not be more trade-restrictive than necessary. The contribution at hand summarises the main findings while taking into account first reactions to the legal appraisal.
机译:REACH法规的目的是确保对人类健康和环境的高度保护,以及物质在内部市场上的自由流通,同时增强竞争力和创新能力。为此,REACH除其他工具外,还引入了法规附件十四中列出的高度关注物质(SVHC)的授权制度。每个附件XIV-SVHC的过渡期到期后,除非获得特定用途的许可或该用途不合格,否则在欧洲经济区(EEA)生产的物品(例如大多数日用产品)可能不包含此类物质。在免除授权要求的范围内。但是,授权方案仅适用于EEA中使用的SVHC。因此,REACH并没有限制SVHC作为进口物品的一部分进入欧洲市场,这些物品对人类健康和环境造成了负担。而且,从经济角度看,国内产品受到的要求比国外生产的产品更为严格,使欧洲经济区内部的参与者处于竞争劣势,从而阻碍了REACH增强竞争力和创新的意图。弥补这一监管空白的一种选择是将授权要求扩展至进口物品中存在的SVHC。代表德国环境局(UBA)进行的法律评估会评估这种选择是否符合WTO世界贸易法的规定。结论是,按照WTO争端解决惯例的标准衡量,这种扩大的授权计划不会违反国民待遇和最惠国待遇原则。同样,此类法规也不会对贸易构成不必要的障碍,因为扩大的授权要求将追求欧盟法规自主权所涵盖的合法目标,此外,该法规不会对贸易造成更大的限制。在考虑法律评估的第一反应的同时,本文的摘要总结了主要发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号